Skip to main content

AI In Life Sciences Investment

ARTO’s AI in Life Sciences Investment Report explores how artificial intelligence is rapidly reshaping biotech and healthtech. The report dives into the investment boom driving AI-first ventures, the evolving talent landscape, shifts in recruitment strategies, and the growing regulatory scrutiny around algorithmic decision-making. With practical insights for investors, founders, and hiring leaders, this report positions ARTO at the centre of the life sciences leadership network. We cover:

  • Discussion of how the surge in AI adoption is straining the talent market – and what life sciences companies are doing to compete for skills.
  • A look at how AI tools are now embedded in recruitment, from sourcing to screening, and how companies are balancing automation with human judgement.
  • Case studies of real-world AI breakthroughs in discovery, diagnostics, and development — and what they mean for the industry’s future.
  • Exploration of how AI is transforming drug development timelines and reshaping clinical operations – pointing toward a new era in biotech.
  • Insight into how AI drug discovery is attracting investors, how platform models are evolving, and what makes AI-first ventures attractive bets.

Download it now to understand how AI is changing the game.